title: Phenylpropanolamine and caffeine use among diet center clients.
abstract: We surveyed phenylpropanolamine (PPA) use and overuse among 309 diet center clients. Fifty-one percent of all subjects surveyed reported using PPA drugs: 44 percent used cold medicines and 16 percent used diet aids. Twenty-two percent of diet aid users and 7 percent of cold medicine users reported that they deliberately used more than the dosage recommended to improve efficacy. Among diet aid users, 59 percent also regularly consumed caffeine. Despite package warnings, individuals who had been told by their doctors that they were hypertensive used PPA products as often as normotensive individuals. PPA, the fifth most frequently used drug in the USA, is contained in over-the-counter (OTC) diet aids as well as OTC and prescription cold medicines. Severe adverse drug reactions (ADRs) including hypertensive crisis, stroke and death have been attributed to PPA products. Clinical studies have shown that using greater than recommended doses of PPA and using PPA in combination with caffeine may increase the risk of ADRs. Overweight patients may be particularly at risk for ADRs to PPA because they are likely to be hypertensive and to use diet aids. We recommend informing diet center clients of the potential dangers of consuming PPA products, especially more than the recommended dose, in the presence of hypertension, and when other sympathomimetic drugs are being taken.
authors.affiliation: Department of Psychiatry, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, MD 20814-4799.
authors.forename: C R
authors.initials: CR
authors.lastname: Lake
authors.forename: D
authors.initials: D
authors.lastname: Rosenberg
authors.forename: R
authors.initials: R
authors.lastname: Quirk
mesh_terms: D000328:Adult; D002110:Caffeine; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010665:Phenylpropanolamine; D019966:Substance-Related Disorders; D013566:Sympathomimetics / Q000009:adverse effects*
chemical_list: D013566:Sympathomimetics; D010665:Phenylpropanolamine; D002110:Caffeine